World's Best Scientists 2026 revealed!
Joseph Schlessinger

Joseph Schlessinger

Award Badge
Best Scientists
2025
Award Badge
Biology and Biochemistry
USA
2026

D-Index & Metrics

Best Scientists

D-Index
195
Citations
157238
World Ranking
349
National Ranking
232

Biology and Biochemistry

D-Index
195
Citations
160231
World Ranking
39
National Ranking
32

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Biology and Biochemistry in United States Leader Award
  • 2023 - Research.com Biology and Biochemistry in United States Leader Award
  • 2014 - BBVA Foundation Frontiers of Knowledge Award
  • 2005 - Member of the National Academy of Medicine (NAM)
  • 2004 - Member of the European Academy of Sciences
  • 2001 - Fellow of the American Academy of Arts and Sciences
  • 2000 - J. Allyn Taylor International Prize in Medicine, Robarts Research Institute
  • 2000 - Member of the National Academy of Sciences
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Joseph Schlessinger is affiliated with Yale University in the United States and has contributed extensively to the fields of biochemistry, genetics, molecular biology, and medicine. Their research spans several subfields, including molecular biology, genetics, oncology, cancer research, and radiology, nuclear medicine, and imaging.

The scientist's work focuses on multiple topics such as fibroblast growth factor research, cytokine signaling pathways and interactions, monoclonal and polyclonal antibodies research, myeloproliferative neoplasms diagnosis and treatment, chronic myeloid leukemia treatments, social media and politics, and neuroblastoma research and treatments.

Recent publications by Joseph Schlessinger include:

  • Design of protein-binding proteins from the target structure alone, 2022, Nature
  • Integrated mutational landscape analysis of uterine leiomyosarcomas, 2021, Proceedings of the National Academy of Sciences
  • Mechanism for the activation of the anaplastic lymphoma kinase receptor, 2021, Nature
  • Structural basis for ligand reception by anaplastic lymphoma kinase, 2021, Nature
  • Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assemblies, 2024, Cell

Frequent co-authors in the scientist's publications include Sangwon Lee, S.G. Krimmer, Jyotidarsini Mohanty, Yoshihisa Suzuki, and Irit Lax.

Their research has been published frequently in venues such as Proceedings of the National Academy of Sciences, bioRxiv (Cold Spring Harbor Laboratory), Nature, Journal of Medicinal Chemistry, and ACS Medicinal Chemistry Letters.

Joseph Schlessinger has received several awards and honors, including:

  • BBVA Foundation Frontiers of Knowledge Award, 2014
  • Member of the National Academy of Medicine (NAM), 2005
  • Member of the European Academy of Sciences, 2004
  • Fellow of the American Academy of Arts and Sciences, 2001
  • J. Allyn Taylor International Prize in Medicine, Robarts Research Institute, 2000
  • Member of the National Academy of Sciences, 2000
  • Member of the European Molecular Biology Organization (EMBO)

Best Publications

  • Signal transduction by receptors with tyrosine kinase activity

    Axel Ullrich;Joseph Schlessinger

  • Cell signaling by receptor-tyrosine kinases

    Mark A. Lemmon;Joseph Schlessinger

  • Mobility measurement by analysis of fluorescence photobleaching recovery kinetics.

    D. Axelrod;D.E. Koppel;J. Schlessinger;E. Elson

  • Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

    A Ullrich;L Coussens;J S Hayflick;T J Dull

  • Close similarity of epidermal growth factor receptor and v- erb-B oncogene protein sequences

    J. Downward;Y. Yarden;E. Mayes;G. Scrace

  • Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

    Lisa Coussens;Teresa L. Yang-Feng;Yu Cheng Liao;Ellson Chen

  • Cellular signaling by fibroblast growth factor receptors.

    V.P. Eswarakumar;I. Lax;J. Schlessinger

  • The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling

    E.J. Lowenstein;R.J. Daly;A.G. Batzer;W. Li

  • Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF -mutant melanoma

    Gideon Bollag;Peter Hirth;James Tsai;Jiazhong Zhang

  • Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

    Y. Yarden;W. J. Kuang;T. Yang-Feng;L. Coussens

  • Growth factor signaling by receptor tyrosine kinases

    J. Schlessinger;A. Ullrich

  • Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

    Towia A. Libermann;Harris R. Nusbaum;Nissim Razon;Richard Kris

  • Protein tyrosine kinase PYK2 involved in Ca 2+ -induced regulation of ion channel and MAP kinase functions

    S. Lev;H. Moreno;R. Martinez;P. Canoll

  • Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

    James Tsai;John T. Lee;Weiru Wang;Jiazhong Zhang

  • Crystal Structure of a Ternary FGF-FGFR-Heparin Complex Reveals a Dual Role for Heparin in FGFR Binding and Dimerization

    Joseph Schlessinger;Alexander N. Plotnikov;Omar A. Ibrahimi;Anna V. Eliseenkova

  • Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor

    Joseph Schlessinger

  • Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.

    Moosa Mohammadi;Gerald McMahon;Li Sun;Cho Tang

  • Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.

    Michael Krauthammer;Yong Lin Kong;Byung Hak Ha;Perry Evans

  • Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation.

    J M Backer;M G Myers;S E Shoelson;D J Chin

  • Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases.

    M. Rozakis-Adcock;J. McGlade;G. Mbamalu;G. Pelicci

Frequent Co-Authors

Irit Lax
Irit Lax Yale University
Axel Ullrich
Axel Ullrich Max Planck Institute of Biochemistry
Mark A. Lemmon
Mark A. Lemmon Yale University
Moosa Mohammadi
Moosa Mohammadi New York University Langone Medical Center
Richard P. Lifton
Richard P. Lifton Rockefeller University
Edward Y. Skolnik
Edward Y. Skolnik New York University
Yosef Yarden
Yosef Yarden Weizmann Institute of Science
David Givol
David Givol Weizmann Institute of Science
Fuyuhiko Inagaki
Fuyuhiko Inagaki Hokkaido University
Sima Lev
Sima Lev Weizmann Institute of Science

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Joseph Schlessinger

Trending Scientists